Medical release archive
Here you can find the archive of all Medical releases prior to 2022
Filter by date:
Showing 102 medical releases before 2023
-
SABINA programme demonstrates SABA reliever overuse is a global issue in asthma management
-
Evusheld long-acting antibody combination retains neutralising activity against Omicron variants including BA.2 in new independent studies
-
New data further reinforce efficacy of Tezspire in a broad population of severe asthma patients
-
Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis
-
Lokelma granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic haemodialysis with hyperkalaemia
-
New sub-analyses further support consistency of Farxiga’s cardiorenal and mortality benefits in treating chronic kidney disease
-
Fasenra granted Orphan Drug and Fast Track Designations in the US for eosinophilic gastritis and eosinophilic gastroenteritis
-
Saphnelo consistently reduces systemic lupus erythematosus disease activity regardless of disease duration and prior treatment
-
CARBON studies showed uncontrolled asthma is associated with an increased carbon footprint of asthma care
-
New Fasenra data from the PONENTE trial show sustained, robust oral corticosteroid reductions in largest ever steroid-sparing trial in severe asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
